Regulatory T cells and CD20+B cells in pediatric very severe aplastic anemia: possible clinical markers for evaluating the therapeutic efficacy and prognosis
Authors:
- 11 July 2018
- journal article
- research article
- Published by Taylor & Francis in Hematology
- Vol. 23 (10) , 823-827
Abstract
Objectives: To investigate the immune status of children with very severe aplastic anemia (VSAA), and evaluate the frequencies of CD20+ B cells and Regulatory T cells (Tregs) as potential markers for evaluating the therapeutic efficacy and prognosis. Methods: We systematically analyzed CD20+ B cells and Tregs using Flow Cytometry in 36 children with VSAA (14 newly diagnosed cases and 22 cases in remission after therapy with HDIVIG + r-ATG + CSA). Results: In newly diagnosed VSAA patients, the percentage of CD20+ B cells was higher than that in healthy children (P < .01), whereas the percentage of Tregs was lower than that in healthy children (P < .001). After treatment with HDIVIG + r-ATG + CSA, the percentage of CD20+ B cells in peripheral blood was decreased obviously, and the percentage of Tregs was significantly increased. Conclusion: There is a moderate negative correlation between the percentage of Tregs and CD20+ B cells in our study. Our results shed light on the roles of Tregs and CD20+ B cells as therapeutic efficacy and prognostic markers of pediatric VSAA. Moreover, the mechanism underlying the decrease of blood Tregs and increase of CD20+ B cells in pediatric VSAA patients have been discussed, indicating that Tregs may suppress B cell responses.Keywords
This publication has 31 references indexed in Scilit:
- Transient depletion of B cells in young mice results in activation of regulatory T cells that inhibit development of autoimmune disease in adultsInternational Immunology, 2012
- Induced Foxp3+ regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?Journal of Molecular Cell Biology, 2011
- Phenotypical and functional specialization of FOXP3+ regulatory T cellsNature Reviews Immunology, 2011
- Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseasesNature Reviews Immunology, 2010
- Guidelines for the diagnosis and management of aplastic anaemiaBritish Journal of Haematology, 2009
- Aplastic anemiaCurrent Opinion in Hematology, 2008
- Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemiaBlood, 2007
- Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of miceNature Immunology, 2006
- Aplastic anemia successfully treated with rituximabAmerican Journal of Hematology, 2005
- Autoantibodies frequently detected in patients with aplastic anemiaBlood, 2003